Literature DB >> 32797183

Subclinical Inflammation and Adipose Tissue Lymphocytes in Pregnant Females With Gestational Diabetes Mellitus.

Anna Cinkajzlová1,2, Kateřina Anderlová3,4, Patrik Šimják4, Zdeňka Lacinová1,2, Jana Kloučková1,2, Helena Kratochvílová1,2, Hana Krejčí3,4, Antonín Pařízek4, Miloš Mráz2,5, Michal Kršek3, Martin Haluzík1,2,5.   

Abstract

CONTEXT: Gestational diabetes mellitus (GDM) is accompanied by subclinical inflammation; however, little is known about local inflammation in adipose tissue and placenta.
OBJECTIVE: To analyze systemic and local subclinical inflammation and adipose tissue lymphocyte content and phenotype in pregnant women with and without GDM.
DESIGN: Observational study. SETTINGS: Academic hospital. PATIENTS: Twenty-one pregnant women with GDM (GDM group), 16 pregnant women without GDM (non-GDM group) and 15 nonpregnant control women (N group).
INTERVENTIONS: Serum samples taken at 28 to 32 (visit 1 [V1]) and 36 to 38 (V2) gestational weeks and 6 to 12 months after delivery (V3) in the GDM and non-GDM group and before elective gynecological surgery in the N group. Subcutaneous (SAT) and visceral adipose tissue (VAT) obtained during cesarean delivery or surgery. MAIN OUTCOME MEASURES: Serum levels and adipose tissue expression of proinflammatory cytokines, adipose tissue lymphocyte content and phenotype (for a subset of GDM and non-GDM subjects).
RESULTS: Accented proinflammatory state in GDM was documented by increased circulating tumor necrosis factor-α (TNF-α) levels. In both groups of pregnant females total lymphocytes were higher in VAT compared to SAT. In GDM subjects B cells and NKT cells were higher in SAT compared to VAT and T helper cells were increased relative to SAT of non-GDM group, while no intercompartmental adipose tissue differences were seen in non-GDM women.
CONCLUSIONS: Pregnant females had higher total lymphocyte count in VAT relative to SAT regardless of GDM. In addition to increased systemic subclinical inflammation, GDM was associated with significant differences in lymphocyte composition between subcutaneous and visceral adipose tissue depots. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adipose tissue; gestational diabetes mellitus; lymphocytes; subclinical inflammation

Year:  2020        PMID: 32797183     DOI: 10.1210/clinem/dgaa528

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Impact of inflammatory factors, hemoglobin A1c, and platelet parameters in gestational diabetes mellitus.

Authors:  Lan-Lan Xiang; Chen Chen; Qian-Yi Wang; Yi-Tian Zhu; Ya-Jun Chen; Yu Zeng
Journal:  Arch Gynecol Obstet       Date:  2022-04-01       Impact factor: 2.344

2.  Putrescine as a Novel Biomarker of Maternal Serum in First Trimester for the Prediction of Gestational Diabetes Mellitus: A Nested Case-Control Study.

Authors:  Cheng Liu; Yuanyuan Wang; Wei Zheng; Jia Wang; Ya Zhang; Wei Song; Aili Wang; Xu Ma; Guanghui Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

3.  NLRP3 inflammasome activation in gestational diabetes mellitus placentas is associated with hydrogen sulfide synthetase deficiency.

Authors:  Wei Wu; Qing-Ying Tan; Fang-Fang Xi; Yun Ruan; Jing Wang; Qiong Luo; Xiao-Bing Dou; Tian-Xiao Hu
Journal:  Exp Ther Med       Date:  2021-11-30       Impact factor: 2.447

4.  Altered Steroidome in Women with Gestational Diabetes Mellitus: Focus on Neuroactive and Immunomodulatory Steroids from the 24th Week of Pregnancy to Labor.

Authors:  Leona Ondřejíková; Antonín Pařízek; Patrik Šimják; Daniela Vejražková; Marta Velíková; Kateřina Anderlová; Michala Vosátková; Hana Krejčí; Michal Koucký; Radmila Kancheva; Michaela Dušková; Markéta Vaňková; Josef Bulant; Martin Hill
Journal:  Biomolecules       Date:  2021-11-23

5.  A Novel Nomogram for Predicting Gestational Diabetes Mellitus During Early Pregnancy.

Authors:  Mei Kang; Hui Zhang; Jia Zhang; Kaifeng Huang; Jinyan Zhao; Jie Hu; Cong Lu; Jiashen Shao; Jianrong Weng; Yuemin Yang; Yan Zhuang; Xianming Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.